Mohammed Rassool to Prospective Studies
This is a "connection" page, showing publications Mohammed Rassool has written about Prospective Studies.
Connection Strength
0,036
-
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med. 2021 08; 9(8):897-908.
Score: 0,036